For COVID-19 vaccine updates, please review our information guide. For patient eligibility and scheduling availability, please visit VaccineTogetherNY.org.
Title: The 22nd international conference on Kaposi's sarcoma-associated herpes virus and related agents
Principal Investigator: Ethel Cesarman, MD, PhD
Period of Support: 04/09/2019 – 03/31/2020
Total Direct Costs: $8,000
Title: Disruption of protein synthesis by cytoplasmic inclusions of RNA-binding proteins drives cytotoxicity and neurodegeneration in ALS/FTD
Principal Investigator: Jessica Tyler, PhD & Slu Sylvia Lee, PhD (Cornell, Ithaca)
Period of Support: 07/01/2019 – 06/30/2020
Total Direct Costs: $75,000
Title: Mechanisms of aberrant DNA double-strand break repair leading to lymphoid malignancy
Principal Investigator: Chun-Chin Chen, PhD (Postdoc, Barry Sleckman Lab)
Period of Support: 07/01/2019 – 06/30/2022
Total Direct Costs: $171,429
Title: Role of novel onco-histone mutations in B-cell malignancies
Principal Investigator: Ethel Cesarman, MD, PhD & Charles David Allis, PhD (Rockefeller)
Period of Support: 08/01/2019 – 07/31/2024
Total Direct Costs: $630,707
Title: HHV-6 in the lymphoma microenvironment
Principal Investigator: Genevieve Crane, MD, PhD & Ethel Cesarman, MD, PhD
Period of Support: 08/06/2019 – 08/05/2020
Total Direct Costs: $9,309
Title: Mechanisms underlying integrated stress response induced inflammation
Principal Investigator: Jihye Paik, PhD
Period of Support: 09/01/2019 – 08/31/2020
Total Direct Costs: $250,000
Title: Targeting skeletal stem cells to treat tumor-induced osteolysis
Principal Investigator: Matthew Greenblatt, MD PhD
Period of Support: 07/01/2019-06/30/2022
Total Direct Costs: $545,454
Title: Targeting metabolic vulnerabilities in primary effusion lymphoma using the novel nucleoside analog (6-ETI)
Principal Investigator: Jouliana Sadek, PhD (Instructor, Ethel Cesarman Lab)
Period of Support: 08/01/2019-07/31/2020
Total Direct Costs: $50,000
Title: Defining molecular determinants of lineage plasticity as a mechanism of treatment resistance in prostate cancer
Principal Investigator: David S. Rickman, PhD
Period of Support: 08/01/2019-07/31/2024
Total Direct Costs: $1,443,165
Title: Recipient epidemiology and donor evaluation study IV-pediatric (REDS-IV-P)- domestic hubs- Phase 1
Principal Investigator: Melissa Cushing, MD
Period of Support: 04/01/2019-03/31/2020
Total Direct Costs: $35,826
Title: The stem cell basis of the bifurcation between adipogenic versus osteogenic lineages
Principal Investigator: Shawon Debnath, PhD (Research Associate, Matthew Greenblatt Lab)
Period of Support: 07/01/2019-06/30/2022
Total Direct Costs: $300,000
Title: Development and in vitro validation of novel antibody therapeutics for vascular disorders
Principal Investigator: Teresa Sanchez, PhD
Period of Support: 04/01/2019-03/31/2020
Total Direct Costs: $100,000
Title: The impact of changes in chromatin architecture on cancer phenotypes and tumor progression
Principal Investigator: Giorgio Inghirami, MD
Period of Support: 06/01/2019-05/31/2020
Total Direct Costs: $121,782
Title: Molecular and clinical correlates with prostate-specific membrane antigen (PSMA)-targeted radionuclide therapy
Principal Investigator: Francesca Khani, MD
Period of Support: 07/01/2019-06/30/2020
Total Direct Costs: $10,331
Title: Prostate cancers with MAPK oncogenic driver mutations: characterizations of a potentially novel and targetable molecular subclass associated with aggressive behavior
Principal Investigator: Francesca Khani, MD
Period of Support: 08/01/2019-07/31/2020
Total Direct Costs: $50,000
Title: Cooption of the DNA damage response for epigenetic regulation of inflammation
Principal Investigator: Steven Josefowicz, PhD
Period of Support: 12/01/2019-11/30/2024
Total Direct Costs: $1,250,000
Title: Endothelial sphingolipid synthesis and tissue inflammatory response
Principal Investigator: Annarita DiLorenzo, PhD
Period of Support: 12/10/2019-11/30/2023
Total Direct Costs: $1,078,000
Title: Enhancing pathology accuracy through artificial intelligence slide review
Principal Investigator: Alain Borczuk, MD
Period of Support: 03/01/2020-12/31/2020
Total Direct Costs: $20,000
Title: Signaling to chromatin pathways in regulation of germinal center B cell differentiation and lymphoma
Principal Investigator: Alexia Martinez De Paz (postdoc in Steven Josefowicz Lab)
Period of Support: 03/01/2020-02/28/2022
Total Direct Costs: $105,000
